Established in Japan in 2003 by researchers from Kyoto University and the University of Tokyo, REPROCELL is a biotech company built around pioneering work with human embryonic and induced pluripotent stem cells. It became an early commercial supplier of iPSC-derived human cells and now supports scientists and therapy developers with stem-cell research and clinical development services.
MHLW license for production of specified processed cell products, Facility No. FA3200006
Registration
European Union Manufacturer Authorization (EMA)
Registration
Good Manufacturing Practice (GMP)
Compliance program
GLP/GCLP
Compliance program
ISO-compliant quality systems
Compliance program
EMA
Quality certification
GMP
Quality certification
GLP
Quality certification
ISO
Quality certification